Aman Chauhan, Leader of Neuroendocrine Cancer Program at Sylvester Comprehensive Cancer Center, shared on X:
“NANETS24 is almost here!
Join us in Chicago (Nov 21-23) to explore the latest advancements in Neuroendocrine Oncology with amazing NET colleagues and enthusiasts.
I’m thrilled to present on two topics that are close to my heart:
Recent Advances in DLL-3 BiTE Targeting of NEC:
- Featuring a case study of one of my patient who achieved a deep, durable response for 2 years after progressing through 5 prior lines of treatment. Will also be summarizing key data from various studies investigating this class of drug. Exciting insights await!
Breaking Ground with a New Drug (CRN 09682) for NETs:
- Will also take a closer look at Paltusotine Phase 2 results and its potential impact for NETs.
Looking forward to sharing and learning with everyone!”
